SUTRO BIOPHARMA, INC. - STRO

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$546.8M
QoQ value delta ($000)
+$187M (+51.96%)
Implied price effect (QoQ)
+32.89%
Shares
Total shares
16,520,797
QoQ shares delta
+2,073,999 (+14.36%)
Total shares held by funds (by quarter)

Market chart (STRO)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 100 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
PERCEPTIVE ADVISORS LLC 43,320 1,304,846 0.65%
BVF INC/IL 41,559 1,251,788 1.06%
Affinity Asset Advisors, LLC 38,926 1,172,487 1.76%
BlackRock, Inc. 37,272 1,122,655 0.0%
Samsara BioCapital, LLC 35,287 1,062,872 2.9%
Kynam Capital Management, LP 28,968 872,558 1.6%
ORBIMED ADVISORS LLC 24,698 743,944 0.46%
BALYASNY ASSET MANAGEMENT L.P. 23,610 711,162 0.03%
VANGUARD CAPITAL MANAGEMENT LLC 23,048 694,219 0.0%
EVENTIDE ASSET MANAGEMENT, LLC 19,430 585,262 0.26%
Velan Capital Investment Management LP 17,003 512,160 10.35%
Woodline Partners LP 15,206 458,029 0.05%
ADAR1 Capital Management, LLC 13,413 404,014 0.61%
GEODE CAPITAL MANAGEMENT, LLC 12,940 389,692 0.0%
ACADIAN ASSET MANAGEMENT LLC 12,405 373,839 0.01%
MILLENNIUM MANAGEMENT LLC 12,150 365,972 0.0%
STATE STREET CORP 10,158 305,979 0.0%
Merck & Co., Inc. 9,042 272,351 1.72%
ACUTA CAPITAL PARTNERS, LLC 8,972 270,251 6.25%
AMERIPRISE FINANCIAL INC 8,123 244,669 0.0%
Point72 Asset Management, L.P. 7,895 237,827 0.01%
KVP Capital Advisors, LP 7,522 226,575 5.52%
UBS Group AG 6,922 208,512 0.0%
TWO SIGMA INVESTMENTS, LP 6,696 201,688 0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC 6,559 197,562 0.0%